UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000031204 |
|---|---|
| Receipt number | R000035619 |
| Scientific Title | A phase II study of robot assisted gastrectomy for gastric cancer |
| Date of disclosure of the study information | 2018/02/09 |
| Last modified on | 2021/02/10 11:07:01 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A phase II study of robot assisted gastrectomy for gastric cancer
Acronym
A phase II study of robot assisted gastrectomy for gastric cancer
Scientific Title
A phase II study of robot assisted gastrectomy for gastric cancer
Scientific Title:Acronym
A phase II study of robot assisted gastrectomy for gastric cancer
Region
| Japan |
Condition
Condition
Patients with clinical stage I or II gastric cancer
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify safety of robot assisted gastrectomy with lymph node dissection
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Phase II
Assessment
Primary outcomes
Postoperative complications greater than Grade III according to Clavien-Dindo classification
Key secondary outcomes
Completion rate of robot assised surgery
The incidence of adverse event
Number of dissected lymph nodes
Oveall survival
Relapse free survival
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
Robot assisted surgery
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Biopsy specimen from the primary lesion shows adenocarcinoma
2) Diagnosed as Stage I or II gastric cancer according to the preoperative esophagogastroduodenoscopy and computer tomography
3) Endoscopic submucosal dissection is not indicated
4) Curative resection is expected by distal gastrectomy or total gastrectomy
5) Eeatern clinical oncology group performans status is 0 or 1
6) Fulfil all following conditions
WBC > 3,000/mm3
Plt > 100,000/mm3
AST < 100 IU/L
ALT < 100IU/L
T.Bil < 2.0 g/dl
Cre < 1.5mg/dl
Key exclusion criteria
1) Having other active cancers
2) Possibly pregnant, or breast feeding woman
3) with psychiatric disorder
4) Receiving steroids
5) With Acute myocardial infaction in 6 months or with unstable ungina
6) With uncontrolled hypertention
7) With uncontrolled diabetes mellitus
8) With pulmonary disease and require continuous oxygen therapy
Target sample size
38
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masakazu Yamamoto |
Organization
Tokyo Women's Medical University
Division name
Department of Gastroenterological Surgery
Zip code
Address
8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
TEL
03-3353-8111
yamamoto@ige.twmu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kiyoaki Taniguchi |
Organization
Tokyo Women's Medical University
Division name
Department of Gastroenterological Surgery
Zip code
Address
8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
TEL
03-3353-8111
Homepage URL
ktaniguchi@twmu.ac.jp
Sponsor or person
Institute
Tokyo Women's Medical University
Institute
Department
Personal name
Funding Source
Organization
Tokyo Women's Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 02 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2018 | Year | 01 | Month | 26 | Day |
Date of IRB
| 2017 | Year | 12 | Month | 01 | Day |
Anticipated trial start date
| 2018 | Year | 01 | Month | 26 | Day |
Last follow-up date
| 2022 | Year | 01 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 02 | Month | 08 | Day |
Last modified on
| 2021 | Year | 02 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035619
